{"DataElement":{"publicId":"2190845","version":"1","preferredName":"Laboratory Procedure CA-125 Antigen Tumor Marker Result Upper Limit of Normal Value","preferredDefinition":"the highest numeric value considered to be a normal result for measuring CA-125 as an indicator of tumor or cancer cells.","longName":"L_CA12_TMM_R_ULN_VAL","context":"CTEP","contextVersion":"2.31","DataElementConcept":{"publicId":"2190059","version":"1","preferredName":"Laboratory Procedure CA-125 Antigen Tumor Marker Result","preferredDefinition":"information related to the result of the medical procedure that involves testing a sample of blood or tissue for CA-125 tumor marker, an antigen expressed by tissues derived from mullerian epithelium (tubal, endometrial and endocervical) or celomic epithelium (mesothelial cells of the pleura, pericardium and peritoneum) and may mean that ovarian cancer present.","longName":"LAB_CA-125_TUMM_RSLT","context":"CTEP","contextVersion":"2.31","ObjectClass":{"publicId":"2543047","version":"1","preferredName":"Test","preferredDefinition":"A procedure for critical evaluation; a means of determining the presence, quality, or truth of something.","longName":"C25294","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Laboratory Procedure","conceptCode":"C25294","definition":"Any procedure that involves testing or manipulating a sample of blood, urine, or other body substance in a laboratory setting.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":"NCI Thesaurus","workflowStatus":"RELEASED","registrationStatus":"Application","id":"2262D258-9F2F-4D98-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-11-16","endDate":null,"createdBy":"IVERSONJ","dateCreated":"2006-11-16","modifiedBy":"ONEDATA","dateModified":"2006-11-16","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"Property":{"publicId":"2738950","version":"1","preferredName":"CA-125 Antigen Tumor Marker Result","preferredDefinition":"An antigen expressed by tissues derived from mullerian epithelium (tubal, endometrial and endocervical) or celomic epithelium (mesothelial cells of the pleura, pericardium and peritoneum).  Although its biochemical nature has not been clearly defined, CA125 has been described as a glycosylated, high-molecular-weight protein that may be released from damaged cells.  Measurable in plasma, CA125 is a sensitive, nonspecific tumour marker for ovarian cancer; as such it is much more useful for monitoring clinical responses to the treatment of ovarian cancer than for the diagnosis of ovarian cancer.  Elevated plasma CA125 may occur in association with other malignancies and non-malignant gynecologic disorders.:A substance sometimes found in an increased amount in the blood, other body fluids, or tissues and which may mean that a certain type of cancer is in the body. Examples of tumor markers include CA 125 (ovarian cancer), CA 15-3 (breast cancer), CEA (ovarian, lung, breast, pancreas, and gastrointestinal tract cancers), and PSA (prostate cancer). Also called biomarker.:Outcome; a phenomenon that follows and is caused by some previous phenomenon.","longName":"C325:C17220:C20200","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"CA-125 Antigen","conceptCode":"C325","definition":"An antigen expressed by tissues derived from mullerian epithelium (tubal, endometrial and endocervical) or celomic epithelium (mesothelial cells of the pleura, pericardium and peritoneum).  Although its biochemical nature has not been clearly defined, CA125 has been described as a glycosylated, high-molecular-weight protein that may be released from damaged cells.  Measurable in plasma, CA125 is a sensitive, nonspecific tumor marker for ovarian cancer; as such it is much more useful for monitoring clinical responses to the treatment of ovarian cancer than for the diagnosis of ovarian cancer.  Elevated plasma CA125 may occur in association with other malignancies and non-malignant gynecologic disorders. (NCI04)","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"2"},{"longName":"Tumor Marker","conceptCode":"C17220","definition":"A substance present in or produced by a tumor or by the host, that can be used for differentiating neoplastic from normal tissue based on measurements in body fluids, secretions, cells, and/or tissues. Markers are used in diagnosis, staging and prognosis of cancer, provide an estimation of tumor burden, and serve for monitoring effects of therapy, detecting recurrence, localization of tumors, and screening in general populations.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Outcome","conceptCode":"C20200","definition":"The result of an action.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"49FDE9EF-992F-04CA-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2008-04-03","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2008-04-03","modifiedBy":"ONEDATA","dateModified":"2008-04-03","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ConceptualDomain":{"publicId":"2008551","version":"1","preferredName":"Assessments","preferredDefinition":"evaluations of the patient and the patient's disease.","longName":"ASSESS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B22DA727-6718-5A2D-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-19","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-19","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E67BAD36-2F04-5129-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-10-15","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2004-10-15","modifiedBy":"SBR","dateModified":"2016-06-06","changeDescription":"**Laboratory Clean-Up**","administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ValueDomain":{"publicId":"2190844","version":"1","preferredName":"CA-125 Antigen Lab Upper Limit of Normal Value","preferredDefinition":"the upper limit of normal for CA-125 as an indicator of tumor or cancer cells.","longName":"CA-125_LAB_ULN_VAL","context":"CTEP","contextVersion":"2.31","type":"Non-enumerated","dataType":"NUMBER","minLength":"1","maxLength":"6","minValue":null,"maxValue":null,"decimalPlace":"3","PermissibleValues":[],"ConceptualDomain":{"publicId":"2008556","version":"1","preferredName":"Assessment Results","preferredDefinition":"the results of evaluations of the patient and the patient's disease.","longName":"ASSESS_RESULTS","context":"CTEP","contextVersion":"2.31","origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"B2D08DE9-38BB-7208-E034-0003BA12F5E7","latestVersionIndicator":"Yes","beginDate":"2002-12-27","endDate":null,"createdBy":"MSUPLEY","dateCreated":"2002-12-27","modifiedBy":"SBR","dateModified":"2003-10-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"RepresentationTerm":{"publicId":"2500946","version":"1","preferredName":"Upper Limit of Normal Value","preferredDefinition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.:A numerical quantity measured or assigned or computed.","longName":"C25706:C25712","context":"NCIP","contextVersion":"1","Concepts":[{"longName":"Upper Limit of Normal","conceptCode":"C25706","definition":"The top value of the range of statistical characteristics that are supposed to represent accepted standard, non-pathological pattern for particular laboratory result or other quantitative parameter.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"No","displayOrder":"1"},{"longName":"Value","conceptCode":"C25712","definition":"A numerical quantity measured or assigned or computed.","evsSource":"NCI_CONCEPT_CODE","primaryIndicator":"Yes","displayOrder":"0"}],"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"19E48A60-907F-415C-E044-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2006-07-31","endDate":null,"createdBy":"CAMPBELB","dateCreated":"2006-07-31","modifiedBy":"ONEDATA","dateModified":"2006-07-31","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"origin":null,"workflowStatus":"RELEASED","registrationStatus":"Application","id":"E7EDBDB1-FA23-4367-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-02","endDate":null,"createdBy":"PWEST","dateCreated":"2004-11-02","modifiedBy":"CAMPBELB","dateModified":"2006-10-04","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"},"ClassificationSchemes":[{"publicId":"2008587","version":"2","longName":"Type of Disease","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811908","version":"1","longName":"Gynecologic","context":"CTEP"}]},{"publicId":"2008589","version":"2","longName":"Type of Category","context":"CTEP","ClassificationSchemeItems":[{"publicId":"2811957","version":"1","longName":"Labs","context":"CTEP"}]},{"publicId":"4057943","version":"1","longName":"Disease Site","context":"NRG","ClassificationSchemeItems":[{"publicId":"10000593","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"4104908","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"10000594","version":"1","longName":"GOG-0212","context":"NRG"},{"publicId":"10000172","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104913","version":"1","longName":"GOG-0241","context":"NRG"},{"publicId":"4104917","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000174","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"10000175","version":"1","longName":"GOG-0262","context":"NRG"},{"publicId":"4104915","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"10000592","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"10000591","version":"1","longName":"GOG-0255","context":"NRG"},{"publicId":"4104899","version":"1","longName":"GOG-0261","context":"NRG"},{"publicId":"10000590","version":"1","longName":"GOG-0252","context":"NRG"},{"publicId":"10000589","version":"1","longName":"GOG-0252","context":"NRG"},{"publicId":"4104914","version":"1","longName":"GOG-0252","context":"NRG"}]}],"AlternateNames":[{"name":"L_CA12_TMM_R_ULN_VAL","type":"USED_BY","context":"NRG"}],"ReferenceDocuments":[{"name":"CA125 Laboratory upper limit","type":"Preferred Question Text","description":"CA125 Laboratory upper limit of normal","url":null,"context":"CTEP"},{"name":"1-COMMENT","type":"COMMENT","description":"unit of measure on CRF: U/mL","url":null,"context":"CTEP"},{"name":"CRF Text","type":"Alternate Question Text","description":"CA125 ULN","url":null,"context":"CTEP"}],"origin":"GOG CRF:Gynecologic Oncology Group Case Report Form","workflowStatus":"RELEASED","registrationStatus":"Qualified","id":"E7EDBF1A-1445-41DF-E034-0003BA3F9857","latestVersionIndicator":"Yes","beginDate":"2004-11-02","endDate":null,"createdBy":"PWEST","dateCreated":"2004-11-02","modifiedBy":"FORMBUILDER","dateModified":"2014-07-29","changeDescription":null,"administrativeNotes":null,"unresolvedIssues":null,"deletedIndicator":"No"}}